FirstLook Lung
Commercial- Indications
- Lung cancer
Company intelligence / Profile preview
DELFI Diagnostics
Palo Alto, California, United Statesdelfidiagnostics.com ↗
- Ownership
- Private
- Employees
- ~54
- Development stage
- Commercial
01
Overview
DELFI Diagnostics has developed a proprietary liquid biopsy platform that uses advanced machine learning and next-generation sequencing to analyze genome-wide cell-free DNA fragmentation patterns in blood samples. Their FirstLook Lung test demonstrates high negative predictive value (99.8%) for lung cancer screening but has not yet received FDA clearance. The company also offers the research-use-only DELFI-TF assay to monitor treatment response in advanced cancers. Multiple presentations at major oncology conferences highlight robust clinical data supporting both early detection and disease monitoring applications.
- Therapeutic areas
- Oncology
- Modalities
- Liquid biopsycell-free DNA (cfDNA) fragmentomics
- Industry
- Molecular Diagnostics
02
Drug pipeline
1 asset03
Partnerships
Eli Lilly & Co. (investor/strategic partnership)Illumina Ventures (investor/technology collaboration potential)
Beyond the preview
Go deeper on DELFI Diagnostics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on DELFI Diagnostics.